AstraZeneca PLC (AZN) vs Alibaba Group Holding Limited (BABA)
AZN leads on 11 of 15 compared metrics, though BABA is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and Alibaba Group Holding Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
AZN
AstraZeneca PLC
$178.75Healthcare
BABA
Alibaba Group Holding Limited
$112.82Consumer Cyclical
Total return — AZN vs BABA
growth of $100 · last 12yAZN +137.7%BABA +20.2%AZN compounded faster
AZN BABA
AZN vs BABA: by the numbers
- •AZN is the larger company ($277.22B vs $270.67B market cap).
- •BABA trades at the lower earnings multiple (18.22 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 10.09% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 6.31% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 0.93%).
Which is better, AZN or BABA?
Metric tally: AZN 11 · BABA 4It depends on what you're optimizing for:
ValueBABA(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | BABA |
|---|---|---|
| P/E ratio | 26.92 | 18.22● |
| Forward P/E | 15.33 | — |
| P/S ratio | 4.62 | 1.87● |
| P/B ratio | 5.90 | 1.77● |
| PEG ratio | 0.14● | 0.23 |
| EV / EBITDA | 14.92 | 13.88● |
| FCF yield | 2.89% | — |
Profitability
| Metric | AZN | BABA |
|---|---|---|
| Gross margin | 81.68%● | 39.77% |
| Operating margin | 23.69%● | 5.78% |
| Net margin | 17.19%● | 10.09% |
| ROE | 21.95%● | 9.58% |
| ROIC | 13.03%● | 3.17% |
Dividends
| Metric | AZN | BABA |
|---|---|---|
| Dividend yield | 1.79%● | 0.93% |
| Payout ratio | 48.48% | 15.89% |
Growth (annualized)
| Metric | AZN | BABA |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 6.31% |
| EPS CAGR (5Y) | 22.02%● | -4.87% |
| FCF CAGR (5Y) | 15.68%● | -62.38% |
| Total return CAGR (5Y) | 11.03%● | -10.73% |
Frequently asked
- Which is better, AZN or BABA?
- It depends on your goal. value: BABA (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 11 to 4.
- Is AZN or BABA cheaper?
- On trailing earnings, BABA is cheaper: AZN trades at a 26.92 P/E and BABA at 18.22.
- Which has grown faster, AZN or BABA?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus BABA at 6.31%.
- Does AZN or BABA pay a bigger dividend?
- AZN yields 1.79% and BABA yields 0.93% based on trailing dividends and the latest price.
- Is AZN or BABA more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus BABA at 10.09%.
- Which has been the better investment, AZN or BABA?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus BABA at 4.68%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioAlibaba Group P/E ratioAstraZeneca dividend yieldAlibaba Group dividend yieldAstraZeneca ROEAlibaba Group ROEAstraZeneca operating marginAlibaba Group operating marginAstraZeneca revenue growthAlibaba Group revenue growthAstraZeneca free cash flowAlibaba Group free cash flow
AstraZeneca & Alibaba Group appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.